Unraveling the Mystery of Microclots: Insights from Leading Researchers

💡Microclots are a common pathological finding in chronic inflammatory conditions, including long COVID and ME/CFS.

🔬Research has shown distinct morphological differences in microclots found in various diseases, indicating unique underlying mechanisms.

🧪Methods such as proteomics and flow cytometry are being developed to detect and analyze microclots, but accessibility is currently limited.

⚕️Despite promising findings, the recognition of microclots by the medical community remains a challenge, leading to skepticism and disbelief among patients.

🌍International collaboration is crucial to advance research on microclots, improve diagnostic methods, and raise awareness among healthcare professionals.

Where can people get tested for microclots?

—Currently, testing for microclots is limited to select research labs and institutions. However, efforts are being made to develop accessible methodologies.

Are the microclots seen in long COVID and ME/CFS similar?

—While both conditions exhibit microclots, the extent and nature of microclot formation differ. Long COVID patients tend to have a higher microclot load, whereas ME/CFS patients show platelet hyperactivation.

What distinguishes microclots found in these conditions from normal clots?

—Microclots in chronic inflammatory conditions exhibit unique morphological characteristics, including an amyloid-like configuration and increased resistance to proteolysis.

How can we overcome the skepticism towards microclots in the medical community?

—Publishing research findings, developing standardized diagnostic methods, and fostering international collaboration can help establish the credibility of microclots and increase recognition among healthcare professionals.

What is the importance of studying microclots in long COVID and ME/CFS?

—Understanding the role of microclots can provide insights into the complex pathophysiology of these conditions, expedite diagnosis, and guide the development of targeted treatments.

00:00Microclots are a common pathological finding in chronic inflammatory conditions.

02:30Distinct morphological differences exist in microclots found in various diseases, indicating unique underlying mechanisms.

05:45Testing for microclots is currently limited to select research labs and institutions.

08:15Long COVID patients exhibit a higher microclot load, while ME/CFS patients show platelet hyperactivation.

10:20Microclots in chronic inflammatory conditions have unique morphological characteristics and increased resistance to proteolysis.

12:50Skepticism towards microclots in the medical community hinders recognition and diagnosis, highlighting the need for published research and standardized methodologies.

15:30International collaboration is crucial to advance research on microclots and raise awareness among healthcare professionals.